Pediatr. praxi. 2008;9(3):177-180

Dermatophytoses in childhood

MUDr. Magdalena Skořepová CSc
Centrum pro dermatomykózy, kožní klinika 1. LF UK a VFN Praha

Dermatophytoses belong to the most frequent skin disorders together with eczematous diseases and crural ulcers both in outpatient and inpatient care. The diseases involve a wide range of population and it is necessary to pay attention also to prevention. They are important from epidemiologic perspective because they are more or less infective. Some persistent disease may warn us about a serious systemic disease (diabetes mellitus, disorders of immune system).

Keywords: dermatophytoses, childhood, differential diagnosis, therapy

Published: August 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Skořepová M. Dermatophytoses in childhood. Pediatr. praxi. 2008;9(3):177-180.
Download citation

References

  1. Alston SJ, Cohen BA, Braun M. Persistent and recurrent tinea corporis in children treated with combination of antifungal/corticosteroid agents. Pediatrics. 2003; 111: 201-203. Go to original source... Go to PubMed...
  2. Devliotou-Panagiotidou D, Koussidou-Eremondi TH. Efficacy and tolerability of 8 weeks' treatment with terbinafine in children with tinea capitis caused by Microsporum canis: a comparison of three doses. J Eur Acad Dermatol Venereol. 2004; 18: 155-159. Go to original source... Go to PubMed...
  3. el Fari M, Gräser Y, Presber W, Tietz HJ. An epidemic of tinea corporis caused by Trichophyton tonsurans among children (wrestlers) in Germany. Mycoses. 2000; 43: 191-196. Go to original source... Go to PubMed...
  4. Elewski BE. Cutaneous mycoses in children. Br J Dermatol. 1996; 134 Suppl 46: 7-11. Go to original source... Go to PubMed...
  5. Ginter-Hanselmayer G, Smolle J, Gupta A. Itraconazole in the treatment of tinea capitis caused by Microsporum canis: experience in a large cohort. Pediatr Dermatol. 2004; 21: 499-502. Go to original source... Go to PubMed...
  6. Gupta AK, Cooper EA, Lynde CW. The efficacy and safety of terbinafine in children. Dermatol Clin. 2003; 21: 511-520. Go to original source... Go to PubMed...
  7. Gupta AK, Skinner AR. Onychomycosis in children: a brief overview with treatment strategies. Pediatr Dermatol. 2004; 21: 80-81. Go to original source... Go to PubMed...
  8. Koussidou-Eremondi T, Devliotou-Panagiotidou D, Mourellou-Tsatsou O, Minas A. Epidemiology of dermatomycoses in children living in Northern Greece 1996-2000. Mycoses. 2005; 48: 11-16. Go to original source... Go to PubMed...
  9. Mohrenschlager M, Schnopp C, Fesq H, Strom K, Beham A, Mempel M, Thomsen S, Brockow K, Wessner DB, Heidelberger A, Ruhdorfer S, Weigl L, Seidl HP, Ring J, Abeck D. Optimizing the therapeutic approach in tinea capitis of childhood with itraconazole. Br J Dermatol. 2000; 143: 1011-1015. Go to original source... Go to PubMed...
  10. Reichert-Pénétrat S, Contet-Audonneau N, Barbaud A, Schurra JP, Fortier B, Schmutz JL. Epidemiology of dermatophytoses in children living in northeast France: a 5-year study. Pediatr Dermatol. 2002; 19(2): 103-105. Go to original source... Go to PubMed...
  11. Thoma-Greber E, Zenker S, Rocken M, Wolff H, Korting HC. Surgical treatment of tinea capitis in childhood. Mycoses. 2003; 46(8): 351-354. Go to original source... Go to PubMed...
  12. Weinstein A, Berman B. Topical treatment of common superficial tinea infections. Am Fam Physician. 2002; 65(10): 2095-2102. Go to PubMed...




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.